NCT06647342 - The Effect of Reduced Bleomycin in Electrochemotherapy Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Cutaneous MetastasisCutaneous Malignant Mixed TumorBleomycin Adverse ReactionElectrochemotherapy

Interventions

DRUG

Bleomycin

In the standard arm, Bleomycin (Baxter, Germany) at a dose of 15.000 IU/m² is used. In the dose reduction arm, a dose of 7500 IU/m² is used. Note that in Denmark bleomycin is dosed by international units, whereas other countries may use respectively U (units) or mg.

Trial Locations (2)

2730

RECRUITING

Copenhagen University Hospital Herlev-Gentofte, Herlev

4000

RECRUITING

Zealand University Hospital, Roskilde

All Listed Sponsors

collaborator

Roskilde University

OTHER

collaborator

Herlev Hospital

OTHER

lead

Julie Gehl

OTHER